Elite Diagnostic Limited (JMSE: ELITE)

Market Cap	639.65M
Revenue (ttm)	827.93M
Net Income (ttm)	20.19M
Shares Out	353.40M
EPS (ttm)	0.05
PE Ratio	34.08
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,897
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	1.250 - 2.620
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 11, 2024

About Elite Diagnostic

Elite Diagnostic Limited provides diagnostic imaging services in Jamaica. The company offers CT scan, MRI, x-ray, ultrasound, and fluoroscopy services. It provides radiology procedures, including angiograms, catheter insertion, aspiration and biopsy, selective hysterosalpingogram and recanalization, lumbar puncture, sclerotherapy, and implant placement services. Elite Diagnostic Limited was incorporated in 2012 and is based in Kingston, Jamaica.

• Industry: Medical Laboratories
• Founded: 2012
• Country: Jamaica
• Stock Exchange: Jamaica Stock Exchange
• Ticker Symbol: ELITE

Financial Performance

In 2024, Elite Diagnostic's revenue was 821.28 million, an increase of 8.73% compared to the previous year's 755.33 million. Earnings were 26.16 million, an increase of 95.90%.